share_log

Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Opaleye Management Inc.(5.14%)

Context Therapeutics | SC 13G:超過5%持股股東披露文件-Opaleye Management Inc.(5.14%)

SEC announcement ·  01/05 00:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息